The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1483
Corrections: Eloctate for Hemophilia A & Sumatriptan Patch (Zecuity) for Migraine
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

Eloctate for Hemophilia A (Med Lett Drugs Ther 2015; 57:143)

In the table on page 144, the indications and half-life listed for Nuwiq were erroneously taken from the European package insert. The table has been revised online to reflect the US prescribing information. The cost for Nuwiq has also been updated.

A Sumatriptan Patch (Zecuity) for Migraine (Med Lett Drugs Ther 2015; 57:151)

In the introduction on page 151, the triptans were referred to as serotonin (5-HT) receptor antagonists; they are ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Corrections: Eloctate for Hemophilia A & Sumatriptan Patch (Zecuity) for Migraine
Article code: 1483f
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian